IDPC welcomes Resolution 60/26 as a landmark affirmation of the Council's authority to address the human rights implications of drug policy, strengthening the UN human rights system and reinforcing calls for health-, rights- and evidence-based drug policies globally.
The upcoming critical review process offers a chance to de-schedule the coca leaf, mitigating prohibition's environmental and social harms, affirming Indigenous rights, and reforming colonial, punitive drug policies.
Montgomery et al. find that U.S. cannabis legalisation reduced overall drug seizures, but racial disparities persisted, underscoring the need for more systemic change.
Health Poverty Action proposes restructuring illegal trades to prioritise public health, equity, and sustainability rather than reproducing harmful market practices.
The UN Human Rights Council denounced the country's racialised drug policing and recommended the decriminalisation of simple possession and the de-prioritisation of people involved in retail.
Recent statistics show a decline in US overdose deaths, but these rates are most likely rising in racialised minority communities due to disproportionate criminalisation and resource scarcity.
The HIV Legal Network provides answers about Canadian drug laws and the criminal justice system to help ACB communities facing systemic discrimination better understand their legal rights.
CERD calls attention to the disproportionate impact of the criminal legal system on racialised people and groups, urging the UK to consistently apply anti-discrimination laws and engage in relevant policy reform.
Release, Amnesty International, UNJUST UK, HRI and IDPC shed light on racial disparities in drug policing and associated human rights violations, urging for decriminalisation, the redirection of resources into care systems, and equitable reform.
UN Special Rapporteur Tlaleng Mofokeng called upon member states to end the war on drugs, as a war on people and a threat to the dignity, health and rights of communities.
Friedman et al. call for expansion of interventions that do not only target overdose death rates but also social inequalities that place minoritised communities at the disadvantage in receiving care
